Inhaled therapy, cardiovascular risk and benefit–risk considerations in COPD: innocent until proven guilty, or vice versa?
COPD management mainly aims at relieving symptoms, and improving exercise tolerance
and quality of life, as well as preventing exacerbations, disease progression and mortality …
and quality of life, as well as preventing exacerbations, disease progression and mortality …
Nonpharmacological interventions in COPD
W Janssens, GM Verleden - European Respiratory Review, 2023 - Eur Respiratory Soc
COPD is recognised as one of the major health challenges for the coming decades. This is
primarily driven by a growing burden of the disease due to persistent exposure to tobacco …
primarily driven by a growing burden of the disease due to persistent exposure to tobacco …
Highlights and hot topics in the management of COPD: where are we heading?
A Agustí, PW Jones, C Vogelmeier - International Journal of …, 2016 - Taylor & Francis
The First World Lung Disease Summit took place in Lisbon over two days in November
2013. This inaugural meeting, of what is hoped to be a long-running annual series, brought …
2013. This inaugural meeting, of what is hoped to be a long-running annual series, brought …
Treatment of COPD: from pharmacological to instrumental therapies
M Alifano, A Cuvelier, A Delage… - European …, 2010 - Eur Respiratory Soc
Treatment guidelines are mainly based on randomised clinical trials that include a small and
highly selected fraction of the COPD population [2]. Therefore, it is questionable as to …
highly selected fraction of the COPD population [2]. Therefore, it is questionable as to …
Towards rational prescription of common inhaler medication in the multimorbid COPD patient
I Tsiligianni, KJ Hoeines, C Jensen… - … Journal of Chronic …, 2021 - Taylor & Francis
COPD is a chronic disease, typically accompanied by multiple comorbid conditions. The
need to apply several, and sometimes conflicting, disease-specific treatment guidelines …
need to apply several, and sometimes conflicting, disease-specific treatment guidelines …
Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities
Owing to its major and better recognised burden from both individual and societal
perspectives, chronic obstructive pulmonary disease (COPD) is an area of intensive …
perspectives, chronic obstructive pulmonary disease (COPD) is an area of intensive …
The Confronting COPD International Survey: patients hardly know they have COPD
PNR Dekhuijzen - European Respiratory Journal, 2002 - Eur Respiratory Soc
An important part of the daily clinical practice of the pulmonologist is related to patients with
chronic obstructive pulmonary disease (COPD). Management of stable COPD includes …
chronic obstructive pulmonary disease (COPD). Management of stable COPD includes …
INDACO project: COPD and link between comorbidities, lung function and inhalation therapy
G Fumagalli, F Fabiani, S Forte, M Napolitano… - Multidisciplinary …, 2015 - Springer
Abstract Background Chronic Obstructive Pulmonary Disease (COPD) is characterized by
respiratory and extrarespiratory components referring both to systemic complications of …
respiratory and extrarespiratory components referring both to systemic complications of …
Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014
J Sundh, J Åberg, M Hasselgren… - European Clinical …, 2017 - Taylor & Francis
Introduction: The aim was to investigate how the pattern of pharmacological treatment in
Swedish patients with chronic obstructive pulmonary disease (COPD) has changed over a …
Swedish patients with chronic obstructive pulmonary disease (COPD) has changed over a …
COPD: still an unpredictable journey
COPD is the fourth leading cause of death and affects nearly 400 million worldwide, causing
much disability as well as early mortality [1]. Management should be tailored to each patient …
much disability as well as early mortality [1]. Management should be tailored to each patient …